The University of Chicago Header Logo
Last Name


Michael H. Davidson to Cholinesterase Inhibitors

This is a "connection" page, showing publications Michael H. Davidson has written about Cholinesterase Inhibitors.

Connection Strength
  1. Adunsky A, Chesnin V, Ravona R, Harats D, Davidson M. Plasma lipid levels in Alzheimer's disease patients treated by Donepezil hydrochloride: a cross-sectional study. Arch Gerontol Geriatr. 2004 Jan-Feb; 38(1):61-8.
    View in: PubMed
    Score: 0.263
  2. Davidson M, Stern RG, Bierer LM, Horvath TB, Zemishlani Z, Markofsky R, Mohs RC. Cholinergic strategies in the treatment of Alzheimer's disease. Acta Psychiatr Scand Suppl. 1991; 366:47-51.
    View in: PubMed
    Score: 0.107
  3. Blesa R, Davidson M, Kurz A, Reichman W, van Baelen B, Schwalen S. Galantamine provides sustained benefits in patients with 'advanced moderate' Alzheimer's disease for at least 12 months. Dement Geriatr Cogn Disord. 2003; 15(2):79-87.
    View in: PubMed
    Score: 0.061
  4. Davidson M. Long-term safety of risperidone. J Clin Psychiatry. 2001; 62 Suppl 21:26-8.
    View in: PubMed
    Score: 0.053
  5. Davidson M, Stern RG. The treatment of cognitive impairment in Alzheimer's disease: beyond the cholinergic approach. Psychiatr Clin North Am. 1991 Jun; 14(2):461-82.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.